Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 67,335 | 70,934 | 69,283 | 72,902 | 68,355 |
| Cost of Goods | 18,228 | 23,811 | 24,581 | 23,621 | 43,152 |
| Gross Profit | 49,107 | 47,123 | 44,702 | 49,281 | 25,203 |
| Operating Expenses | 52,907 | 63,714 | 59,333 | 52,363 | 46,220 |
| Operating Income | -3,572 | -15,780 | -14,050 | -2,461 | -20,865 |
| Interest Expense | 5,127 | 5,226 | 2,589 | 1,859 | 1,601 |
| Other Income | 1,147 | 1,293 | -3,197 | 326 | 338 |
| Pre-tax Income | -7,552 | -19,713 | -19,836 | -3,994 | -22,128 |
| Income Tax | 45 | 30 | 30 | -21 | 36 |
| Net Income Continuous | -7,597 | -19,743 | -19,866 | -3,973 | -22,164 |
| Net Income | $-7,597 | $-19,743 | $-19,866 | $-3,973 | $-22,164 |
| EPS Basic Total Ops | -0.19 | -0.49 | -0.52 | -0.12 | -0.59 |
| EPS Basic Continuous Ops | -0.19 | -0.49 | -0.52 | -0.11 | -0.59 |
| EPS Diluted Total Ops | -0.19 | -0.49 | -0.52 | -0.12 | -0.59 |
| EPS Diluted Continuous Ops | -0.19 | -0.49 | -0.52 | -0.11 | -0.59 |
| EBITDA(a) | $3,152 | $-8,764 | $-9,367 | $1,941 | $-16,446 |